Harel Insurance Investments & Financial Services Ltd. Kempharm, Inc Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 26, 2021	SELL	$8.52 - $15.47 $170,400 - $309,400	-20,000 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$5.6 - $13.47 $112,000 - $269,400	20,000 New	20,000 $615,000

Others Institutions Holding KMPH

# of Institutions

115

Shares Held

26.1M

Call Options Held

591K

Put Options Held

242K

Woodline Partners LP San Francisco, CA

4.05M
Shares

$20 Million
0.18% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.92M
Shares

$14.4 Million
0.86% of portfolio
Vanguard Group Inc Valley Forge, PA

2.76M
Shares

$13.6 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.7M
Shares

$13.3 Million
0.0% of portfolio
Altium Capital Management LP New York, NY

1.7M
Shares

$8.4 Million
2.96% of portfolio

View Full List

About KEMPHARM, INC

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

More about KMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account